Use of split-course hypofractionated radiotherapy in palliative treatment of head and neck cancers: how does our regimen compare with others?
- 9 March 2023
- journal article
- research article
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 22, e83
- https://doi.org/10.1017/s1460396922000322
Abstract
Introduction: Head and neck cancers (HNCs) are some of the commonest cases requiring palliative radiotherapy (PRT) in an Indian radiotherapy practice. A variety of PRT protocols have been explored with varying success. Methods: The study objective was to evaluate the efficacy and tolerability of a short-course hypofractionated PRT schedule in HNC patients in terms of symptom relief, tumour response, acute side effects and survival and to compare results with other PRT regimens. All patients received 30 Gy in 10 fractions over 2 weeks followed by another 20 Gy in 5 fractions after a 4 weeks gap. Results: Seventy-five percent of patients completed both phases of treatment. Symptom relief was seen in 71% (pain) to 76% (dysphagia) of patients. Tumour response was recorded in 73% of patients. At 12 months, the mean overall survival was 10·29 months for patients who responded to PRT compared to 7·87 months for those who did not. Results were comparable to other regimens reported in the literature, but no radiobiological advantage of a higher dose was discernible. Conclusions: Short-course hypofractionated PRT is effective in reducing tumour burden and relieving symptoms in HNC patients and possibly in lengthening survival. Selection of any schedule should be decided by treating oncologists based on clinical, logistic and socio-economic factors.Keywords
This publication has 29 references indexed in Scilit:
- The Role of Split-course Hypofractionated Palliative Radiotherapy in Head and Neck CancerClinical Oncology, 2011
- Hypofractionated radiotherapy denoted as the “Christie scheme”: An effective means of palliating patients with head and neck cancers not suitable for curative treatmentActa Oncologica, 2009
- Quad shot: A short but effective schedule for palliative radiation for head and neck carcinomaIndian Journal of Palliative Care, 2009
- Hypofractionated, palliative radiotherapy for advanced head and neck cancerRadiotherapy and Oncology, 2008
- Palliative radiation therapy for head and neck cancer: Toward an optimal fractionation schemeHead & Neck, 2008
- Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment – “Hypo Trial”Radiotherapy and Oncology, 2007
- A review of hypofractionated palliative radiotherapyCancer, 2007
- The ‘QUAD SHOT’—a phase II study of palliative radiotherapy for incurable head and neck cancerRadiotherapy and Oncology, 2005
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)Endocrine, 1995
- High Fractional Dose Irradiation of Advanced Head and Neck Cancer: Implications for Combined Radiotherapy and SurgeryJAMA Otolaryngology–Head & Neck Surgery, 1983